CHD2 antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
DNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression(By similarity).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | chromodomain helicase DNA binding protein 2 (CHD2) |
| Host | Rabbit |
| Reactivity | Human, Rat |
| Recommended Dilution | WB: 1:500-1:2000; IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 95 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, IHC, WB |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | O14647 |
| Gene ID | 1106 |
| Alias | Chromodomain-helicase-DNA-binding protein 2 (CHD-2),ATP-dependent helicase CHD2,CHD2 |
| Background | Antibody anti-CHD2 |
| Status | RUO |
| Note | Mol. Weight 95 kDa |
Descripción
Related Products
CHD2 antibody
DNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression(By similarity).
Ver Producto
Recombinant Human CHD2
Ver Producto
Chromodomain Helicase DNA Binding Protein 2 (CHD2) Antibody
CHD2 Antibody is a Rabbit Polyclonal antibody against CHD2. The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
Ver Producto